PPD in the News
Movement for real-world evidence as PPD and Evidera launch new research unit
CenterWatch reports on the combining of PPD’s medical affairs operations team and Evidera.
Acurian: new consulting service provides ‘continuum of support’
Outsourcing-Pharma reports on the introduction of Acurian Consulting Services.
PPD expands Virginia vaccine lab with an eye on assays
A report on the expansion of the PPD® Laboratories vaccine sciences lab in Richmond, Virginia, as reported in Outsourcing-Pharma.
PPD valued at more than $9bn as investors recapitalize
Outsourcing-Pharma provides insight into PPD's recapitalization.
Singapore, UAE government funds’ new investments put PPD at $9B
PPD’s recapitalization covered in FierceBiotech.
PPD builds clinical research associates apprentice program, targets military veterans
FierceBiotech reports on PPD’s new, industry-first CRA apprentice program that focuses on military veterans.
An analysis of specific Phase I safety issues
Kirsten Messmer co-authored this article that focuses on the importance of maximizing safety in clinical trials.
Mass Spectrometry Measures Up to Analytical Challenges
Jie Ding discusses the importance of mass spectrometry in assigning the primary structure of biologic drugs.
The need for—and barriers to—adopting eSource
John Manns discusses the use of electronic approaches at clinical trial sites.